Biotech

All Articles

Zephyrm looks for Hong Kong IPO to finance stage 3 cell treatment trials

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock exchange, filing (PDF) for an IP...

Frazier Life Sciences gets $630M for little, mid-cap biotechs

.Frazier Daily life Sciences has actually sourced an even more $630 thousand for its fund concentrat...

GigaGen amasses up to $135M BARDA dollars to beat botox

.Antitoxin aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its technici...

GPCR firm Septerna declare IPO on toughness of preclinical data

.Septerna is about to learn exactly how a biotech without "any purposeful scientific records" fares ...

Kurma shuts to begin with $154M payload for greatest biotech fund yet

.European VC firm Kurma Allies has actually revealed its own most current biotech fund, along with 1...

Prothena markets one officer while yet another leaves behind-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of notable management hirings, firings as wel...

Editas exploit Tip Cas9 licensing legal rights for $57M

.Versus the backdrop of a Cas9 license struggle that refuses to pass away, Editas Medication is cash...

Ultragenyx adjusts genetics treatment application to call up efficiency

.A minority of people taking Ultragenyx Pharmaceutical's Wilson health condition genetics therapy UX...

Biopharma layoff cost supports in Q3: Fierce Biotech study

.As summer months heat energy looks to cool winds, hopes that this year would carry wide-spread indu...

J &amp J drops phase 2 dengue candidate in newest change from vaccines

.Johnson &amp Johnson's deprioritization of its infectious illness pipeline has professed another pr...